Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: AIDS Care. 2010 Feb;22(2):137–145. doi: 10.1080/09540120903038366

Table 2.

Median differences from baseline in self-reported 30 day recall outcomes (number of days over the past 30 experiencing symptom) among 222 HIV-positive patients on antiretroviral therapy in western Kenya

Health not good
Pain made usual activities hard
Days on
ART
N
Crude
Median
(IQR)*
Adjusted
change from
0-30***
adjusted
p-val**
N
Crude
Median
(IQR)*
Adjusted
change from
0-30***
adjusted
p-val**
0-30 32 7 (3 - 14) ref 37 7 (3 - 14) ref
31-90 33 5 (1 - 14) -3.0 0.221 34 3 (0 - 14) -3.0 0.0305
91-180 53 3 (0 - 7) -5.0 0.010 55 1 (0 - 4) -6.0 <.0001
181-270 52 3 (0 - 7) -4.5 0.031 54 1 (0 - 3) -6.0 <.0001
271-360 60 3 (0 - 7) -4.5 0.034 63 0 (0 - 4) -6.0 <.0001
361-450 61 3 (0 - 7) -4.0 0.054 67 2 (0 - 4) -4.0 <.0001
451-540 74 3 (0 - 7) -4.0 0.035 75 2 (0 - 5) -4.0 <.0001
541-630 67 0 (0 - 7) -6.5 0.001 67 0 (0 - 4) -6.0 <.0001
631-720 78 3 (1 - 7) -4.0 0.043 79 3 (0 - 5) -4.0 <.0001
*

IQR = Interquartile range

**

Adjusted for age, sex, WHO stage at baseline using quantile regression and bootstrapped p-values

***

Estimated using quantile regression